TANAKA makes an equity contribution to Ambix Life Science Fund
healthcaretechoutlook

TANAKA makes an equity contribution to Ambix Life Science Fund

Healthcare Tech Outlook | Tuesday, September 14, 2021

Contributions stimulate investment in medical companies and support international healthcare advancement.

FREMONT, CA: TANAKA invests in Ambix Life Science Fund I, L.P., a medical device venture fund managed by Ambix Venture Management, LLC, a venture capital firm based in the United States. TANAKA will use its equity commitment to strengthen both its local and international company development and offer the development of safe and secure healthcare industry.

TANAKA provides medical device manufacturers with precious metal components and materials and engages in development initiatives, collaborating with and contributing to healthcare advancement. In addition, the company has previously made equity contributions to multiple medical device venture funds and has decided to contribute to Ambix Ventures' venture fund, which is based in Silicon Valley, one of the epicenters of medical device innovation, to provide even more support to the healthcare industry's development. TANAKA is investing in the fund, which is managed by Aaron Berez, MD, a leading healthcare entrepreneur, and Peter N. Townshend, to strengthen its ties with the U.S. healthcare industry and contribute to the advancement of cutting-edge healthcare through the use of precious metal components and materials in the healthcare field.

"The world has changed with the advent of the COVID-19 Coronavirus pandemic. However, it has also underscored the importance of the global healthcare infrastructure and challenges. We at Ambix are excited to be a small part of this ongoing challenge, in our case the continuing mission to make healthcare more efficient. We welcome TANAKA's participation as part of the Ambix team." said Dr. Berez, manager at Ambix Ventures.

TANAKA is a precious metals professional organization with a diverse range of goods, including bonding wires and fuel cell catalysts, that command a high market share. The Group uses a recycling-oriented business model to supply steady supplies of precious metals, which are valued resources, from procurement to product development and recycling. TANAKA has always focused on the healthcare industry to contribute to society while utilizing precious metals' qualities. The company provides precious metal components and materials to local and international medical device makers and contracts manufacturing in-vitro diagnostic kits that use gold colloids.

Weekly Brief